Insulin-dependent diabetes mellitus and its animal models

Current Opinion in Immunology

Volumn 11, Issue 6, 1999, Pages 643-647

  Wong, F Susan ^a   Janeway Jr, Charles A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GLUTAMATE DECARBOXYLASE; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

DIABETOGENESIS; DISEASE COURSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; SHORT SURVEY; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0032748135     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00031-X     Document Type: Review

References (62)

1. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1983;1337-1339.
2. Baekkeskov S., Nielsen J.H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immuno-precipitate human pancreatic islet cell proteins. Nature. 298:1982;167-169.
3. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., DeCamilli P., Camilli P.D. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156. [Published erratum appears in Nature 1990, 347:782.].
4. Christie M.R., Genovese S., Cassidy D., Bosi E., Brown T.J., Lai M., Bonifacio E., Bottazzo G.F. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes. 43:1994;1254-1259.
5. Hawkes C.J., Wasmeier C., Christie M.R., Hutton J.C. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes. 45:1996;1187-1192.
6. Solimena M., Dirkx R. Jr., Hermel J.M., Pleasic-Williams S., Shapiro J.A., Caron L., Rabin D.U. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J. 15:1996;2102-2114.
7. Verge C.F., Stenger D., Bonifacio E., Colman P.G., Pilcher C., Bingley P.J., Eisenbarth G.S. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes. 47:1998;1857-1866.
8. Bingley P.J., Bonifacio E., Williams A.J., Genovese S., Bottazzo G.F., Gale E.A. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 46:1997;1701-1710.
9. Roep B.O. Standardization of T-cell assays in type I diabetes. Immunology of Diabetes Society T-cell Committee. Diabetologia. 42:1999;636-637. [letter].
10. Myers M.A., Laks M.R., Feeney S.J., Mandel T.E., Koulmanda M., Bone A., Barley J., Rowley M.J., Mackay I.R. Antibodies to ICA512/IA-2 in rodent models of IDDM. J Autoimmun. 11:1998;265-272.
11. Mackay I.R., Bone A., Tuomi T., Elliott R., Mandel T., Karopoulos C., Rowley M.J. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus. J Autoimmun. 9:1996;705-711.
12. Atkinson M.A., Leiter E.H. The NOD mouse model of type 1 diabetes as good as it gets? Nat Med. 5:1999;601-604. This review examines the strengths and weaknesses of the NOD mouse model of diabetes and summarises therapies that have prevented diabetes in this model.
13. Smith K.M., Olson D.C., Hirose R., Hanahan D. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance. Int Immunol. 9:1997;1355-1365.
14. Vafiadis P., Bennett S.T., Todd J.A., Nadeau J., Grabs R., Goodyer C.G., Wickramasinghe S., Colle E., Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 15:1997;289-292.
15. Pugliese A., Zeller M., Fernandez A. Jr., Zalcberg L.J., Bartlett R.J., Ricordi C., Pietropaolo M., Eisenbarth G.S., Bennett S.T., Patel D.D. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 15:1997;293-297.
16. Heath V.L., Moore N.C., Parnell S.M., Mason D.W. Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun. 11:1998;309-318.
17. Throsby M., Homo-Delarche F., Chevenne D., Goya R., Dardenne M., Pleau J.M. Pancreatic hormone expression in the murine thymus: localization in dendritic cells and macrophages. Endocrinology. 139:1998;2399-2406.
18. Sospedra M., Ferrer-Francesch X., Dominguez O., Juan M., Foz-Sala M., Pujol-Borrell R. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J Immunol. 161:1998;5918-5929.
19. Daniel D., Gill R.G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol. 25:1995;1056-1062.
20. Daniel D., Wegmann D.R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA. 93:1996;956-960.
21. + T cell. This was found to be an insulin B-chain peptide and has important implications for insulin as an autoantigen.
22. French M.B., Allison J., Cram D.S., Thomas H.E., Dempsey-Collier M., Silva A., Georgiou H.M., Kay T.W., Harrison L.C., Lew A.M. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes. 46:1997;34-39. [Published erratum appears in Diabetes 1997, 46:924].
23. Cetkovic-Cvrlje M., Gerling I.C., Muir A., Atkinson M.A., Elliot J.F., Leiter E.H. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens. Diabetes. 46:1997;1975-1982. [Published erratum appears in Diabetes 1998, 47:303].
24. Carrasco-Marin E., Shimizu J., Kanagawa O., Unanue E.R. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol. 156:1996;450-458.
25. Carrasco-Marin E., Kanagawa O., Unanue E.R. The lack of consensus for I-A(g7)-peptide binding motifs: is there a requirement for anchor amino acid side chains? Proc Natl Acad Sci USA. 96:1999;8621-8626.
26. Kanagawa O., Martin S.M., Vaupel B.A., Carrasco-Marin E., Unanue E.R. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc Natl Acad Sci USA. 95:1998;1721-1724.
27. Nagata M., Santamaria P., Kawamura T., Utsugi T., Yoon J.W. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol. 152:1994;2042-2050.
28. Wong F.S., Visintin I., Wen L., Flavell R.A., Janeway C.A. Jr. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med. 183:1996;67-76.
29. Yoneda R., Yokono K., Nagata M., Tominaga Y., Moriyama H., Tsukamoto K., Miki M., Okamoto N., Yasuda H., Amano K., Kasuga M. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice. Diabetologia. 40:1997;1044-1052.
30. DiLorenzo T.P., Graser R.T., Ono T., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., Serreze D.V. Major histo-compatibility complex class I and restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc Natl Acad Sci USA. 95:1998;12538-12543.
31. Rammensee H.G., Falk K., Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol. 11:1993;213-244.
32. Raju R., Munn S.R., David C.S. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice. Hum Immunol. 58:1997;21-29.
33. Congia M., Patel S., Cope A.P., De Virgiliis S., Sonderstrup G. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci USA. 95:1998;3833-3838.
34. Schloot N.C., Willemen S., Duinkerken G., de Vries R.R., Roep B.O. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain. J Autoimmun. 11:1998;169-175.
35. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA. 88:1991;10252-10256.
36. Hutchings P., Cooke A. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration. J Autoimmun. 11:1998;127-130.
37. Harrison L.C., Dempsey-Collier M., Kramer D.R., Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med. 184:1996;2167-2174.
38. Karounos D.G., Bryson J.S., Cohen D.A. Metabolically inactive insulin analog prevents type I and diabetes in prediabetic NOD mice. J Clin Invest. 100:1997;1344-1348.
39. Zekzer D., Wong F.S., Wen L., Altieri M., Gurlo T., von Grafenstein H., Sherwin R.S. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes. 46:1997;1124-1132.
40. Kim J., Richter W., Aanstoot H.J., Shi Y., Fu Q., Rajotte R., Warnock G., Baekkeskov S. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes. 42:1993;1799-1808.
41. Petersen J.S., Russel S., Marshall M.O., Kofod H., Buschard K., Cambon N., Karlsen A.E., Boel E., Hagopian W.A., Hejnaes K.R.et al. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes. 42:1993;484-495.
42. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
43. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
44. Tian J., Atkinson M.A., Clare-Salzler M., Herschenfeld A., Forsthuber T., Lehmann P.V., Kaufman D.L. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med. 183:1996;1561-1567.
45. Tian J., Clare-Salzler M., Herschenfeld A., Middleton B., Newman D., Mueller R., Arita S., Evans C., Atkinson M.A., Mullen Y.et al. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med. 2:1996;1348-1353.
46. Zekzer D., Wong F.S., Ayalon O., Millet I., Altieri M., Shintani S., Solimena M., Sherwin R.S. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J Clin Invest. 101:1998;68-73.
47. Panina-Bordignon P., Lang R., van Endert P.M., Benazzi E., Felix A.M., Pastore R.M., Spinas G.A., Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med. 181:1995;1923-1927.
48. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest. 94:1994;2125-2129.
49. Katz J.D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell. 74:1993;1089-1100.
50. Bergman B., Haskins K. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes. 43:1994;197-203.
51. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 4:1998;781-785. The BDC2.5 TCR-transgenic mouse model was used to show that diabetes was accelerated following infection with Coxsackie virus. As the T cells have not been shown to respond to the virus, the implication is that acceleration is due to inflammation and bystander activation of cells rather than molecular mimicry.
52. Geng L., Solimena M., Flavell R.A., Sherwin R.S., Hayday A.C. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease. Proc Natl Acad Sci USA. 95:1998;10055-10060.
53. Bridgett M., Cetkovic-Cvrlje M., O'Rourke R., Shi Y., Narayanswami S., Lambert J., Ramiya V., Baekkeskov S., Leiter E.H. Differential protection in two transgenic lines of NOD/Lt mice hyper-expressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes. 47:1998;1848-1856.
54. Yoon J.W., Yoon C.S., Lim H.W., Huang Q.Q., Kang Y., Pyun K.H., Hirasawa K., Sherwin R.S., Jun H.S. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science. 284:1999;1183-1187. This study uses a transgenic construct encoding antisense GAD-65 and GAD-67. It was shown that, in the line where GAD-65 and GAD-67 were most completely suppressed, not only were insulitis and diabetes abolished but also cells from these mice could not cause disease on adoptive transfer; transfer of diabetic spleen cells did not destroy the islets from the antisense-transgenic mice.
55. Wicker L.S., Chen S.L., Nepom G.T., Elliott J.F., Freed D.C., Bansal A., Zheng S., Herman A., Lernmark A., Zaller D.M.et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest. 98:1996;2597-2603.
56. Patel S.D., Cope A.P., Congia M., Chen T.T., Kim E., Fugger L., Wherrett D., Sonderstrup-McDevitt G. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice. Proc Natl Acad Sci USA. 94:1997;8082-8087.
57. Liu J., Purdy L.E., Rabinovitch S., Jevnikar A.M., Elliott J.F. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes. 48:1999;469-477.
58. Boyton R.J., Lohmann T., Londei M., Kalbacher H., Halder T., Frater A.J., Douek D.C., Leslie D.G., Flavell R.A., Altmann D.M. Glutamic acid decarboxylase, T. and lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int Immunol. 10:1998;1765-1776.
59. Wen L., Wong F.S., Burkly L., Altieri M., Mamalaki C., Kioussis D., Flavell R.A., Sherwin R.S. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice. J Clin Invest. 102:1998;947-957. [Published erratum appears in J Clin Invest 1998, 102:1463] This paper demonstrates the effect of adoptive transfer of GAD-peptide-reactive T cell lines into HLA-DQ8-transgenic mice. It shows that the lines will not cause insulitis or diabetes unless the recipients are given a mild islet insult in the form of low-dose streptozotocin.
60. Anonymous: The diabetes prevention trial-type 1 diabetes (DPT-1): implementation of screening and staging of relatives. DPT-1 Study Group. Transplant Proc 1995, 27:3377.
61. Carel J.C., Bougneres P.F. Treatment of prediabetic patients with insulin: experience and future. European Prediabetes Study Group. Horm Res. 45:1996;44-47.
62. Petersen J.S., Mackay P., Plesner A., Karlsen A., Gotfredsen C., Verland S., Michelsen B., Dyrberg T. Treatment with GAD65 or BSA does not protect against diabetes in BB rats. Autoimmunity. 25:1997;129-138.